Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
January 28, 2025 5:19 PM 3 min read

Trump's Federal Spending Freeze Puts $3 Trillion In Limbo, Threatens Industries Like Clean Energy, Defense, Health Care

by Piero Cingari Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

The White House has ordered a temporary freeze on all federal grants and loans, putting $3 trillion in funding under scrutiny and setting the stage for a legal and political showdown over the congressional power of the purse that could heavily impact a wide range of industries.

The directive, issued Monday by the Office of Management and Budget and received by several media outlets, requires all federal agencies to halt disbursements while programs are reviewed for alignment with President Donald Trump's policy priorities.

This includes halting new awards, existing payment and funding for projects until reviewed.

The exact financial impact of the order remains uncertain. Budget experts cited by the Washington Post estimate at least tens of billions of dollars are at stake, though the White House directive suggests the total could be significantly higher.

Of the almost $10 trillion spent by the federal government in fiscal 2024, more than $3 trillion was federal financial assistance, Matthew Vaeth, acting director at the OMB, said in the memorandum.

“Financial assistance should be dedicated to advancing Administration priorities,” Vaeth said, adding that “the use of Federal resources to advance Marxist equity, transgenderism, and green new deal social engineering policies is a waste of
taxpayer dollars that does not improve the day-to-day lives of those we serve.”

The White House said that Social Security and Medicare remain untouched. The sweeping pause threatens funding for universities, nonprofits, contractors and private companies that depend on federal assistance.

“Nothing in this memo should be construed to impact Medicare or Social Security benefits,” the memo said.

The immediate focus will be on how agencies handle exemptions. The OMB memo allows federal departments to request case-by-case approvals, which means some funding may still flow, but the process is likely to be slow and politically charged.

Federal agencies have until Feb. 10, 2025, to provide OMB with detailed reports outlining which programs, projects, and activities are affected by the funding pause.

Legal, Political Showdown Over Federal Funds

The move is triggering legal challenges from nonprofits and Democratic-led states.

Within hours of the announcement, lawsuits were filed in federal courts in New York, Illinois and Oregon, arguing that Trump does not have the authority to withhold congressionally approved spending.

Senate Minority Leader Chuck Schumer was among the first to push back, saying Congress-approved investments are legally mandated and asserting the president lacks the authority to override the Impoundment Control Act of 1974, which restricts unilateral executive control over federal funds.

Trump has long argued that the 1974 law is unconstitutional, stating that past presidents had far more discretion over spending before its passage.

Which Industries Could Face Trouble?

Some of the hardest-hit sectors could include clean energy, defense, health care and education, where federal dollars have played a crucial role in driving investment and growth in recent years.

Trump's OMB memo explicitly targeted climate initiatives and green energy programs. Shares of solar and renewable energy companies were among the hardest hit following the federal funding freeze.

The Invesco Solar ETF (NYSE:TAN) and the Invesco Wilderhill Clean Energy ETF (NYSE:PBW) fell by 2% and 1.3%, respectively, on Tuesday.

The impact on health care remains unclear. While Medicare is shielded, Medicaid funding — which supports hospitals, managed care providers and pharmaceutical companies — could be at risk.

Read Next:

  • Fed Set To Signal No Rush To Cut Rates As Wall Street Awaits Policy Clarity

Photo via Shutterstock.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EquitiesGovernmentLarge CapRegulationsSector ETFsPoliticsEcon #sTop StoriesMarketsMoversETFsDonald TrumpStories That Matter
HCA Logo
HCAHCA Healthcare Inc
$538.211.06%
Overview
LMT Logo
LMTLockheed Martin Corp
$654.480.25%
NOC Logo
NOCNorthrop Grumman Corp
$739.000.37%
PBW Logo
PBWInvesco WilderHill Clean Energy ETF
$32.39-1.97%
RTX Logo
RTXRTX Corp
$203.900.42%
RUN Logo
RUNSunrun Inc
$11.92-0.43%
SEDG Logo
SEDGSolarEdge Technologies Inc
$35.200.03%
TAN Logo
TANInvesco Solar ETF
Not Available-%
THC Logo
THCTenet Healthcare Corp
$225.000.12%
UHS Logo
UHSUniversal Health Services Inc
$190.49-%

Sunnova Energy International Inc. (NYSE:NOVA) dropped 12%, Sunrun Inc. (NASDAQ:RUN) fell 9.2% and SolarEdge Technologies Inc. (NASDAQ:SEDG) declined 5%.

Defense contractors such as Lockheed Martin Corp. (NYSE:LMT), RTX Corp. (NYSE:RTX) and Northrop Grumman (NYSE:NOC) may also see rising uncertainty. While military spending is unlikely to be cut outright, several defense contractors rely on federal grants for research and development.

HCA Healthcare Inc. (NYSE:HCA) and Universal Health Services Inc. (NYSE:UHS) fell by 1% and 1.4%, respectively, while Tenet Healthcare Corp. (NYSE:THC) showed resilience Tuesday.

HCA Logo
HCAHCA Healthcare Inc
$538.211.06%
Overview
LMT Logo
LMTLockheed Martin Corp
$654.480.25%
NOC Logo
NOCNorthrop Grumman Corp
$739.000.37%
PBW Logo
PBWInvesco WilderHill Clean Energy ETF
$32.39-1.97%
RTX Logo
RTXRTX Corp
$203.900.42%
RUN Logo
RUNSunrun Inc
$11.92-0.43%
SEDG Logo
SEDGSolarEdge Technologies Inc
$35.200.03%
TAN Logo
TANInvesco Solar ETF
Not Available-%
THC Logo
THCTenet Healthcare Corp
$225.000.12%
UHS Logo
UHSUniversal Health Services Inc
$190.49-%
Comments
Loading...